Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 77,383 | 63,798 | 47,517 | N/A |
| TOTAL | $80,506 | $65,062 | $48,242 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,707 | 4,159 | 1,913 | N/A |
| Other Non-Current Assets | 389 | 389 | 236 | 0 |
| TOTAL | $4,096 | $4,548 | $2,149 | $N/A |
| Total Assets | $84,602 | $69,610 | $50,391 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,143 | 1,771 | 1,106 | 0 |
| Accrued Expenses | 3,642 | 2,488 | 1,492 | N/A |
| Other current liabilities | 471 | 384 | 650 | N/A |
| TOTAL | $9,256 | $4,643 | $3,248 | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 4,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,225 | 969 | 905 | 0 |
| TOTAL | $2,225 | $969 | $905 | $N/A |
| Total Liabilities | $11,481 | $5,612 | $4,153 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 3,042 | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 1 | N/A |
| Retained earnings | -161,950 | -118,953 | -82,806 | N/A |
| Other shareholders' equity | 20 | 160,509 | 108,038 | 0 |
| TOTAL | $73,121 | $63,998 | $46,238 | $N/A |
| Total Liabilities And Equity | $84,602 | $69,610 | $50,391 | $0 |